Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Miss Estimates
Portfolio Pulse from
Ironwood Pharmaceuticals (IRWD) reported Q4 earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.10. This is an improvement from break-even earnings per share a year ago.
February 27, 2025 | 2:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ironwood Pharmaceuticals reported Q4 earnings of $0.02 per share, missing the expected $0.10. This is an improvement from last year's break-even earnings.
The earnings miss is likely to negatively impact IRWD's stock price in the short term as it fell short of analyst expectations. However, the improvement from last year's break-even earnings may mitigate some negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100